Skip to main content
Erschienen in: Supportive Care in Cancer 2/2016

01.02.2016 | Original Article

Diagnostic accuracy of the Catheter Injection and Aspiration (CINAS) classification for assessing the function of totally implantable venous access devices

verfasst von: G. A. Goossens, Y. De Waele, M. Jérôme, S. Fieuws, C. Janssens, M. Stas, P. Moons

Erschienen in: Supportive Care in Cancer | Ausgabe 2/2016

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Intravenous catheters are used for the administration of intravenous therapy and for blood sampling. These devices are considered as well-functioning if both the injection and aspiration are easy. Malfunction is frequently observed and usually vaguely described as occlusion. We developed the CINAS, the Catheter Injection and Aspiration scheme. The CINAS is a catheter function classification tool, which classifies both the injection and the aspiration ability in a uniform way. Each CINAS class consists of a combination of an injection (IN) and an aspiration (AS) code: e.g. IN1AS1 is the CINAS class for a well-functioning catheter. In this series, we aimed to determine the accuracy of the CINAS class reported by nurses, after minimal training, versus a trained researcher, acting as a reference standard.

Methods

Catheter function was assessed during a standard blood sampling procedure through a totally implantable venous access device in a convenience sample of 150 oncology patients. One nurse researcher and 111 oncology nurses both scored the catheter function according to the CINAS classification scheme, independently. Concordance between the scores was calculated.

Results

For the 140 catheters scored as well-functioning (IN1AS1 score) by the researcher, 139 or 99.3 % (95 % confidence interval (CI) 96.1–99.9 %) were scored correctly by the nurse participants. Nine out of ten or 90 % (95 % CI 55.5–98.3 %) of malfunctioning catheters (researcher scores different from IN1AS1) were also identified as malfunctioning by the nurse participants and received exactly the same CINAS score in eight cases (80 %, 95 % CI 44.4–97.5 %). The overall accuracy of the CINAS scored by the nurse participants versus the researcher is (139 + 9)/150 or 98.7 % (95 % CI 95.3–99.8 %).

Conclusions

Nurse participants were able to classify the catheter function of totally implantable venous access devices with the CINAS accurately after a brief explanation about the classification options.
Literatur
2.
Zurück zum Zitat Pikwer A, Baath L, Davidson B, Perstoft I, Akeson J (2008) The incidence and risk of central venous catheter malpositioning: a prospective cohort study in 1619 patients. Anaesth Intensive Care 36:30–37PubMed Pikwer A, Baath L, Davidson B, Perstoft I, Akeson J (2008) The incidence and risk of central venous catheter malpositioning: a prospective cohort study in 1619 patients. Anaesth Intensive Care 36:30–37PubMed
3.
Zurück zum Zitat Skaff ER, Doucette S, McDiarmid S, Huebsch L, Sabloff M (2012) Vascular access devices in leukemia: a retrospective review amongst patients treated at the Ottawa Hospital with induction chemotherapy for acute leukemia. Leuk Lymphoma 53:1090–1095. doi:10.3109/10428194.2011.639879 PubMedCrossRef Skaff ER, Doucette S, McDiarmid S, Huebsch L, Sabloff M (2012) Vascular access devices in leukemia: a retrospective review amongst patients treated at the Ottawa Hospital with induction chemotherapy for acute leukemia. Leuk Lymphoma 53:1090–1095. doi:10.​3109/​10428194.​2011.​639879 PubMedCrossRef
4.
Zurück zum Zitat Cesaro S, Corro R, Pelosin A, Gamba P, Zadra N, Fusaro F, Pillon M, Cusinato R, Zampieri C, Magagna L, Cavaliere M, Tridello G, Zanon G, Zanesco L (2004) A prospective survey on incidence and outcome of Broviac/Hickman catheter-related complications in pediatric patients affected by hematological and oncological diseases. Ann Hematol 83:183–188. doi:10.1007/s00277-003-0796-9 PubMedCrossRef Cesaro S, Corro R, Pelosin A, Gamba P, Zadra N, Fusaro F, Pillon M, Cusinato R, Zampieri C, Magagna L, Cavaliere M, Tridello G, Zanon G, Zanesco L (2004) A prospective survey on incidence and outcome of Broviac/Hickman catheter-related complications in pediatric patients affected by hematological and oncological diseases. Ann Hematol 83:183–188. doi:10.​1007/​s00277-003-0796-9 PubMedCrossRef
5.
Zurück zum Zitat Lim MY, Al-Kali A, Ashrani AA, Begna KH, Elliott MA, Hogan WJ, Hook CC, Kaufmann SH, Letendre L, Litzow MR, Patnaik MS, Pardanani A, Tefferi A, Wolanskyj AP, Grill DE, Pruthi RK (2013) Comparison of complication rates of Hickman (®) catheters versus peripherally inserted central catheters in patients with acute myeloid leukemia undergoing induction chemotherapy. Leuk Lymphoma 54:1263–1267. doi:10.3109/10428194.2012.742520 PubMedCrossRef Lim MY, Al-Kali A, Ashrani AA, Begna KH, Elliott MA, Hogan WJ, Hook CC, Kaufmann SH, Letendre L, Litzow MR, Patnaik MS, Pardanani A, Tefferi A, Wolanskyj AP, Grill DE, Pruthi RK (2013) Comparison of complication rates of Hickman (®) catheters versus peripherally inserted central catheters in patients with acute myeloid leukemia undergoing induction chemotherapy. Leuk Lymphoma 54:1263–1267. doi:10.​3109/​10428194.​2012.​742520 PubMedCrossRef
6.
Zurück zum Zitat Surov A, Wienke A, Carter JM, Stoevesandt D, Behrmann C, Spielmann RP, Werdan K, Buerke M (2009) Intravascular embolization of venous catheter—causes, clinical signs, and management: a systematic review. JPEN J Parenter Enteral Nutr 33:677–685. doi:10.1177/0148607109335121 PubMedCrossRef Surov A, Wienke A, Carter JM, Stoevesandt D, Behrmann C, Spielmann RP, Werdan K, Buerke M (2009) Intravascular embolization of venous catheter—causes, clinical signs, and management: a systematic review. JPEN J Parenter Enteral Nutr 33:677–685. doi:10.​1177/​0148607109335121​ PubMedCrossRef
7.
Zurück zum Zitat Stephens LC, Haire WD, Kotulak GD (1995) Are clinical signs accurate indicators of the cause of central venous catheter occlusion? JPEN J Parenter Enteral Nutr 19:75–79PubMedCrossRef Stephens LC, Haire WD, Kotulak GD (1995) Are clinical signs accurate indicators of the cause of central venous catheter occlusion? JPEN J Parenter Enteral Nutr 19:75–79PubMedCrossRef
8.
Zurück zum Zitat Baskin JL, Pui CH, Reiss U, Wilimas JA, Metzger ML, Ribeiro RC, Howard SC (2009) Management of occlusion and thrombosis associated with long-term indwelling central venous catheters. Lancet 374:159–169PubMedPubMedCentralCrossRef Baskin JL, Pui CH, Reiss U, Wilimas JA, Metzger ML, Ribeiro RC, Howard SC (2009) Management of occlusion and thrombosis associated with long-term indwelling central venous catheters. Lancet 374:159–169PubMedPubMedCentralCrossRef
9.
Zurück zum Zitat Nakazawa N (2010) Infectious and thrombotic complications of central venous catheters. Semin Oncol Nurs 26:121–131PubMedCrossRef Nakazawa N (2010) Infectious and thrombotic complications of central venous catheters. Semin Oncol Nurs 26:121–131PubMedCrossRef
10.
Zurück zum Zitat Goossens GA, Vrebos M, De Wever I, Stas M (2004) Vacutainer filling time through subcutaneous venous access devices. J Vasc Access 5:154–160PubMed Goossens GA, Vrebos M, De Wever I, Stas M (2004) Vacutainer filling time through subcutaneous venous access devices. J Vasc Access 5:154–160PubMed
11.
Zurück zum Zitat Verhamme P, Goossens G, Maleux G, Collen D, Stas M (2007) A dose-finding clinical trial of staphylokinase SY162 in patients with long-term venous access catheter thrombotic occlusion. J Thromb Thrombolysis 24:1–5PubMedCrossRef Verhamme P, Goossens G, Maleux G, Collen D, Stas M (2007) A dose-finding clinical trial of staphylokinase SY162 in patients with long-term venous access catheter thrombotic occlusion. J Thromb Thrombolysis 24:1–5PubMedCrossRef
12.
Zurück zum Zitat Horne MK III, Mayo DJ (1997) Low-dose urokinase infusions to treat fibrinous obstruction of venous access devices in cancer patients. J Clin Oncol 15:2709–2714PubMed Horne MK III, Mayo DJ (1997) Low-dose urokinase infusions to treat fibrinous obstruction of venous access devices in cancer patients. J Clin Oncol 15:2709–2714PubMed
13.
Zurück zum Zitat Frank JL, Garb JL, Halla B, Reed WP Jr (2001) Ionic implantation of silicone chronic venous access devices does not alter thrombotic complications: a double-blinded, randomized clinical trial. Surgery 129:547–551PubMedCrossRef Frank JL, Garb JL, Halla B, Reed WP Jr (2001) Ionic implantation of silicone chronic venous access devices does not alter thrombotic complications: a double-blinded, randomized clinical trial. Surgery 129:547–551PubMedCrossRef
14.
Zurück zum Zitat Carlo JT, Lamont JP, McCarty TM, Livingston S, Kuhn JA (2004) A prospective randomized trial demonstrating valved implantable ports have fewer complications and lower overall cost than nonvalved implantable ports. Am J Surg 188:722–727PubMedCrossRef Carlo JT, Lamont JP, McCarty TM, Livingston S, Kuhn JA (2004) A prospective randomized trial demonstrating valved implantable ports have fewer complications and lower overall cost than nonvalved implantable ports. Am J Surg 188:722–727PubMedCrossRef
15.
Zurück zum Zitat Stevens B, Barton SE, Brechbill M, Moenter S, Piel AL, Shankle D (2000) A randomized, prospective trial of conventional vascular ports vs. the vortex “clear-flow” reservoir port in adult oncology patients. JVAD 5(4):37–40 Stevens B, Barton SE, Brechbill M, Moenter S, Piel AL, Shankle D (2000) A randomized, prospective trial of conventional vascular ports vs. the vortex “clear-flow” reservoir port in adult oncology patients. JVAD 5(4):37–40
16.
Zurück zum Zitat Johansson E, Bjorkholm M, Bjorvell H, Hast R, Takolander R, Olofsson P, Backman L, Weitzberg E, Engervall P (2004) Totally implantable subcutaneous port system versus central venous catheter placed before induction chemotherapy in patients with acute leukaemia—a randomized study. Support Care Cancer 12:99–105PubMedCrossRef Johansson E, Bjorkholm M, Bjorvell H, Hast R, Takolander R, Olofsson P, Backman L, Weitzberg E, Engervall P (2004) Totally implantable subcutaneous port system versus central venous catheter placed before induction chemotherapy in patients with acute leukaemia—a randomized study. Support Care Cancer 12:99–105PubMedCrossRef
17.
Zurück zum Zitat Goossens GA, Stas M, Moons P (2012) Management of functional complications of totally implantable venous access devices by an advanced practice nursing team: 5 years of clinical experience. Eur J Oncol Nurs S1462-3889(11):00173–6. doi:10.1016/j.ejon.2011.11.006 Goossens GA, Stas M, Moons P (2012) Management of functional complications of totally implantable venous access devices by an advanced practice nursing team: 5 years of clinical experience. Eur J Oncol Nurs S1462-3889(11):00173–6. doi:10.​1016/​j.​ejon.​2011.​11.​006
18.
Zurück zum Zitat Sauerland C, Engelking C, Wickham R, Corbi D (2006) Vesicant extravasation part I: mechanisms, pathogenesis, and nursing care to reduce risk. Oncol Nurs Forum 33:1134–1141PubMedCrossRef Sauerland C, Engelking C, Wickham R, Corbi D (2006) Vesicant extravasation part I: mechanisms, pathogenesis, and nursing care to reduce risk. Oncol Nurs Forum 33:1134–1141PubMedCrossRef
19.
Zurück zum Zitat Goossens GA, Kerschaever I, Despierre E, Stas M (2013) Access of a fully rotated implantable port leads to extravasation. J Vasc Access 14:299–300. doi:10.5301/jva.5000136, C4F9D654-8A58-4478-A3A5-603E3616D9DB PubMedCrossRef Goossens GA, Kerschaever I, Despierre E, Stas M (2013) Access of a fully rotated implantable port leads to extravasation. J Vasc Access 14:299–300. doi:10.​5301/​jva.​5000136, C4F9D654-8A58-4478-A3A5-603E3616D9DB PubMedCrossRef
20.
Zurück zum Zitat Infusion Nursing Standards of Practice (2011) J Infus Nurs 34:S1–110CrossRef Infusion Nursing Standards of Practice (2011) J Infus Nurs 34:S1–110CrossRef
21.
Zurück zum Zitat Perez Fidalgo JA, Garcia FL, Cervantes A, Margulies A, Vidall C, Roila F (2012) Management of chemotherapy extravasation: ESMO–EONS Clinical Practice Guidelines. Eur J Oncol Nurs 16:528–534PubMedCrossRef Perez Fidalgo JA, Garcia FL, Cervantes A, Margulies A, Vidall C, Roila F (2012) Management of chemotherapy extravasation: ESMO–EONS Clinical Practice Guidelines. Eur J Oncol Nurs 16:528–534PubMedCrossRef
Metadaten
Titel
Diagnostic accuracy of the Catheter Injection and Aspiration (CINAS) classification for assessing the function of totally implantable venous access devices
verfasst von
G. A. Goossens
Y. De Waele
M. Jérôme
S. Fieuws
C. Janssens
M. Stas
P. Moons
Publikationsdatum
01.02.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Supportive Care in Cancer / Ausgabe 2/2016
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-015-2839-x

Weitere Artikel der Ausgabe 2/2016

Supportive Care in Cancer 2/2016 Zur Ausgabe

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

CUP-Syndrom: Künstliche Intelligenz kann Primärtumor finden

30.04.2024 Künstliche Intelligenz Nachrichten

Krebserkrankungen unbekannten Ursprungs (CUP) sind eine diagnostische Herausforderung. KI-Systeme können Pathologen dabei unterstützen, zytologische Bilder zu interpretieren, um den Primärtumor zu lokalisieren.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.